The largest database of trusted experimental protocols

Epiq 7 ultrasound machine

Manufactured by Philips
Sourced in United States

The EPIQ 7 Ultrasound Machine is a diagnostic imaging device manufactured by Philips. It is designed to capture high-quality ultrasound images of various parts of the human body. The device utilizes advanced imaging technologies to provide detailed visualization of anatomical structures and assist healthcare professionals in their clinical assessments.

Automatically generated - may contain errors

8 protocols using epiq 7 ultrasound machine

1

CTPA Evaluation for Pulmonary Embolism Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Echocardiography evaluation was done by an expert cardiologist with a high‐resolution device (Philips, EPIQ 7 Ultrasound Machine). CTPA was done under the supervision of an expert radiologist with a 16‐slices device (Siemens, Somatom emotion) (voltage 100–120 kVP, pitch 1.5, rotation time 0.6 s, detector width 16 × 0.6 mm) through a two‐step selective test bolus method. In the first step as the test step, 15–30 cc of the Visipaque (iodixanol injectable contrast medium for intravascular use) contrast (350 mg/cc) was injected with a flow rate of 5–6 cc/s and multiple scans were done from the pulmonary artery bifurcation. By the test injection, the delay time was calculated by the dynaeva option of the device, and the delay time was used for the imaging protocol of the main step with an injection of 70–90 cc of the contrast with the same flow rate and the scans were obtained from the pulmonary artery. The results of CTPA were reported by the radiologist regardless of the echocardiography and the clinical status of the patients.
+ Open protocol
+ Expand
2

Comprehensive Transthoracic Echocardiography Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A basic comprehensive 2-dimensional transthoracic echocardiography was performed by a senior cardiologist who was blinded to the KCG measurements, with a Philips Epiq 7 ultrasound machine using a Philips X5-1 transducer (Eindhoven, The Netherlands).
The left ventricular outflow tract (LVOT) dimensions were obtained in the parasternal long-axis view during systole. The velocity time integral (VTI) at the LVOT was measured in the apical five-chamber view using pulsed-wave Doppler, and stroke volume (SV) was calculated using the following equation: SV = LVOT VTI × Cross Sectional Area of the LVOT (17 (link)). The left ventricular (LV) ejection fraction (LVEF) was measured with a modified Simpson's method (18 ). QRS duration was automatically measured for each of the 12-lead morphological analysis and expressed as ms, using the inbuilt software Extended Measurements Report of a Philips PageWriter TC50 electrocardiograph (Philips Medical Systems, Andover, MA, USA).
+ Open protocol
+ Expand
3

Intraprocedural TEE Guidance for LAA Occlusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intraprocedural TEE was performed for guidance of the procedure. All TEE studies were performed under conscious sedation by an advanced imaging cardiologist using an EPIQ 7 ultrasound machine and an X8-2T TEE probe (Philips Medical Systems, Amsterdam, Netherlands), as described previously (14 (link)). The LAA was visualized in 0°, 45°, 90° and 135° from a midesophageal approach (10 (link)). The ostium was defined as a line between tip of the coumadine ridge and the circumflex artery. The LZ was defined as the line 10 mm distal from the ostium perpendicular to the long axis of the LAA. The depth was defined as a straight line from the midpoint of the ostium plane to the LAA roof. Device sizing was based on LZ maximum diameter according to manufacturer's instructions.
+ Open protocol
+ Expand
4

Transesophageal Echocardiography for Detecting Left Atrial Appendage Thrombus

Check if the same lab product or an alternative is used in the 5 most similar protocols
TOE studies were executed by certified echocardiographers (second-degree accreditation in echocardiography of the Section of Echocardiography of the Polish Cardiac Society (PCS)). TOE examinations are conducted directly or a few hours before the scheduled procedure (usually at 48 hours prior to the procedure) in all engaged reference cardiology centers. To the examination was used the EPIQ 7 Ultrasound Machine (Philips Medical Systems, Andover, MA) or the iE33 ultrasound machine (Philips Medical Systems) with the X72t TOE ultrasound transducer (Philips Medical Systems). LAAT was defined as a well circumscribed echogenic mass with a unique echotexture contrasting with the surrounding endocardium or pectinate muscles and detected in more than 1 imaging plane. Spontaneous echocardiographic contrast, defined as a dynamic “smoke-like” signal with a distinctive swirling motion, occurs due to increased ultrasonic density without creating a discrete mass. In the case of suspected LAAT occurrence, the examination was consulted with additional echocardiographer. In a doubtful event, 3 qualified echocardiographers evaluated the study to establish a correct diagnosis. Written informed consents for TOE examination were obtained from each engaged individual.
+ Open protocol
+ Expand
5

Echocardiographic Evaluation Before ECV

Check if the same lab product or an alternative is used in the 5 most similar protocols
In all the centers, transthoracic echocardiography examinations were conducted prior to the scheduled ECV in most patients. All exams were performed by certified echocardiographers (second-degree accreditation in echocardiography of the Section of Echocardiography of the Polish Cardiac Society [PCS]), using the General Electric Vivid 7 or E95 Ultrasound System (General Electric, Milwaukee, Wisconsin), the EPIQ 7 Ultrasound Machine (Philips Medical Systems, Andover, Massachusetts, USA), or the iE33 Ultrasound Machine (Philips Medical Systems, Andover, Massachusetts, USA). The analysis included the left atrial anteroposterior diameter, the left ventricular end-diastolic diameter, the left ventricular end-systolic diameter and the left ventricular ejection fraction (LVEF).
+ Open protocol
+ Expand
6

Cardiac MRI and Echocardiography Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 1.5-T magnet was used for the CMR imaging. End-expiration images were acquired with electrocardiographic gating. Following anatomical imaging, long-and short-axis cine images were acquired using steady state free precession-based sequences. A bolus intravenous injection of 0.1mmol/kg gadobutrol (Gadovist, Bayer PLC, Berkshire, UK) was administered. Over 10 to 15 minutes, LGE images were acquired using gradient echo-based sequences and some with steady state free precession sequences.
The transthoracic echocardiograms (TTE) were performed with a Philips Epiq 7
ultrasound machine and an X5-1 xMATRIX array transducer (Philips Healthcare, Andover, MA). The images were acquired using power modulation modality (Left Ventricular Opacification -LVO vendor specific pre-set) with second harmonic imaging (1.3/2.6MHz) and the mechanical index was set at 0.8-1.0 in line with previously published data [16] (link). The gain was adjusted above the noise floor and below saturation level, according to each patient's ultrasound reflectivity. The 3D datasets were acquired with a 4-or 6-beat acquisition or highvolume rate (HVR) mode with breath holding and the lateral and elevation angles were adjusted to enclose the entire left ventricle (LV).
+ Open protocol
+ Expand
7

Carotid Artery Duplex Doppler Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Duplex Doppler carotid artery scan was performed using a GE Agilent Image Point HXB.1 Sonos 4500/5500B.1 ultrasound system or a Philips Epiq7 ultrasound machine (Philips Ultrasound, Inc., Bothell, WA, USA). B-mode, color- and pulsed-wave Doppler analyses were performed on both sides to identify arterial wall lesions, stenoses, and occlusions. Stenosis was expressed as the percentage decrease in artery diameter, using the ECST criteria [22 (link)].
Where no plaques were identified, carotid intima-media thickness (IMT) was measured bilaterally at the far wall of the common carotid artery, immediately proximal to bifurcation, in end-diastole. The higher IMT value was introduced into the statistic calculations. Carotid artery atherosclerosis was considered to be present when an IMT > 1.00 mm, or the presence of plaques at any level was found.
+ Open protocol
+ Expand
8

Transesophageal Echocardiographic Imaging of LAA

Check if the same lab product or an alternative is used in the 5 most similar protocols
TEE Imaging was performed using Phillips EPIQ 7 ultrasound machine and Phillips IE33 ultrasound transducer (Andover, Massachusetts). Standard TEE images were acquired including focused imaging of the LA and LAA. Technique routinely used at our institution involves acquisition of at least two orthogonal views of the LAA. All TEEs were reviewed by at least one of two echocardiographers with strong agreement between observers (Cohen’s kappa: 0.89). A thrombus was reported if a well-circumscribed, echo-reflective mass distinct from the LA endocardium or pectinate muscles was present in the appendage or body of the LA[4 (link)]. Spontaneous echo contrast (SEC) was classified as dense, clearing, or absent correlating with 3-4+, 1-2+, or 0 as graded by Fatkin et al[25 (link)] SEC was classified as dense if a dense swirling pattern was observed in the LAA and was detectable throughout the cardiac cycle (with variable intensity). SEC was classified as clearing if minimal echodensity was observed in the LAA and was detectable transiently during the cardiac cycle. LAA velocities were determined based on peak velocities averaged over a minimum of two full cardiac cycles in the view which was most parallel to the LAA ostium. LA size was assessed semi-quantitatively and documented as normal, mildly, moderately, or severely dilated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!